Background3.0 T non‐contrast‐enhanced nitroglycerin (NTG)‐assisted whole‐heart coronary magnetic resonance angiography (MRA) employing Dixon water‐fat separation and compressed SENSE (CS‐SENSE) acceleration is a promising method for diagnosing coronary artery disease (CAD).PurposeTo evaluate the diagnostic performance of this technique for detecting clinically‐relevant (≥50% diameter reducing) CAD and to evaluate the difference in NTG‐induced coronary vasodilation between patients with and without clinically‐relevant CAD.Study TypeProspective.PopulationSixty‐six patients with suspected CAD.Field Strength/Sequence3.0 T; CSSENSE, Dixon water‐fat separation, three‐dimensional segmented turbo field gradient‐echo sequence for whole‐heart coronary MRA.AssessmentOverall image quality of coronary MRA was calculated on the basis of all visible coronary segments. The diagnostic performance of coronary MRA for detecting a ≥50% reduction in coronary artery diameter with and without NTG was compared using X‐ray coronary angiography (CAG) as the reference. According to CAG, patients were divided into a non‐clinically‐relevant CAD group and clinically‐relevant CAD group, and the difference in NTG‐induced vasodilation between the groups was evaluated.Statistical TestsUnpaired/paired Student's t‐test, Mann–Whitney U test, paired Wilcoxon signed‐rank test, χ2 test, McNemar test. A two‐tailed P value <0.05 was considered significant.ResultsOverall image quality was increased significantly in the coronary MRA images after NTG. The diagnostic performance of the non‐NTG vs. NTG‐assisted coronary MRA was as follows on a per‐patient basis: sensitivity 94.3% vs. 94.3%, specificity 64.5% vs. 83.9%, positive predictive value 75.0% vs. 86.8%, negative predictive value 90.9% vs. 92.9%, and accuracy 80.3% vs. 89.4%, respectively. NTG‐induced vasodilation was significantly lower in the clinically‐relevant CAD group than in the non‐clinically‐relevant CAD group (13.7 ± 8.1% vs. 24.1 ± 16.3%).Data ConclusionNon‐contrast Dixon water‐fat separation CS‐SENSE coronary MRA at 3.0 T can noninvasively detect clinically‐relevant CAD and sublingual NTG improved performance. Combining pre‐ and post‐NTG coronary MRA may provide a simple noninvasive and nonionizing test to evaluate coronary vasodilation function.Level of Evidence1Technical Efficacy Stage2